Works matching IS 00099236 AND DT 2025 AND VI 117 AND IP 4

Results: 37

Bench to Budget: Integrated Evidence Generation for Medications.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 869, doi. 10.1002/cpt.3603

By:

Schneeweiss, Sebastian;
Miksad, Rebecca

Publication type:

Article

In this Issue.

Published in:: Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 867, doi. 10.1002/cpt.3602
Publication type:: Article

Modern Evidence Generation on Medication Effectiveness and Safety During Pregnancy: Study Design Considerations.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 895, doi. 10.1002/cpt.3598

By:

Huybrechts, Krista F.;
Bateman, Brian T.;
Hernández‐Díaz, Sonia

Publication type:

Article

Franchise Data Strategy: "PIVOT"ing From Cognitive Dissonance Toward Making What Is Implicit, Explicit.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 891, doi. 10.1002/cpt.3597

By:

Bhattacharya, Indranil;
Rathmann, Suchitrita;
Najdi, Safaa;
Ahmed, Mariam A.;
Heatherington, Anne

Publication type:

Article

Clinical Evidence 2030.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 884, doi. 10.1002/cpt.3596

By:

Arlett, Peter;
Umuhire, Denise;
Verpillat, Patrice;
Foggi, Paolo;
Wändel Liminga, Ulla;
Sepodes, Bruno;
Lunzer, Marianne;
Aylward, Brian;
Vamvakas, Spiros;
Roes, Kit;
Pétavy, Frank;
Thirstrup, Steffen;
Lamas, Maria;
Cooke, Emer;
Broich, Karl

Publication type:

Article

Highlighted Articles.

Published in:: Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 872, doi. 10.1002/cpt.3595
Publication type:: Article

Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 938, doi. 10.1002/cpt.3579

By:

Emond, Sarah K.;
Goettsch, Wim G.;
Ollendorf, Daniel A.

Publication type:

Article

Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 946, doi. 10.1002/cpt.3576

By:

Chen, Jie;
Gruber, Susan;
Lee, Hana;
Chu, Haitao;
Lee, Shiowjen;
Tian, Haijun;
Wang, Yan;
He, Weili;
Jemielita, Thomas;
Song, Yang;
Tamura, Roy;
Tian, Lu;
Zhao, Yihua;
Chen, Yong;
van der Laan, Mark;
Nie, Lei

Publication type:

Article

ASCPT News.

Published in:: Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 874, doi. 10.1002/cpt.3594
Publication type:: Article

Palbociclib Is Safe for Breast Cancer Patients With Mild Hepatic Impairment: A Multicenter Retrospective Study Using Real‐World Data.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1115, doi. 10.1002/cpt.3574

By:

Bos, Alieke K.;
Willemsen, Annelieke E.C.A.B.;
Visser, Loes E.;
Stoker, Lennart J.;
Kingma, Jurjen S.;
Rommers, Mirjam K.;
Kuck, Emile M.;
van der Linden, Paul D.;
van Nuland, Merel

Publication type:

Article

Correction to "Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies".

Published in:: Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1148, doi. 10.1002/cpt.3592
Publication type:: Article

Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012–2021.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1131, doi. 10.1002/cpt.3589

By:

Choi, Yoona;
Won, Jung‐Hyun;
Kim, Heeju;
Hong, YeSol;
Kim, Yujin;
Lee, Howard

Publication type:

Article

Comparative Effectiveness of First‐Line Pembrolizumab vs. Chemotherapy in aNSCLC: A Norwegian Population‐Based Cohort Study.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1123, doi. 10.1002/cpt.3591

By:

Brant, Simon Boge;
Børø, Siri;
Jonasson, Christian;
Helland, Åslaug;
Thoresen, Steinar

Publication type:

Article

Pediatric Pharmacoepidemiology and Drug Development From a Regulatory Perspective.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 881, doi. 10.1002/cpt.3587

By:

McMahon, Ann W.;
Horton, Daniel B.;
Mulugeta, Yeruk;
Yao, Lynne

Publication type:

Article

Planning Post‐Launch Evidence Generation: Lessons From France, England and Spain.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 961, doi. 10.1002/cpt.3586

By:

Kent, Seamus;
Meyer, Francois;
Pavel, Alina;
Saborido, Carlos Martin;
Austin, Catrin;
Williamson, Steve;
Ray, Joshua;
Facey, Karen

Publication type:

Article

Chat GPT vs. Clinical Decision Support Systems in the Analysis of Drug–Drug Interactions.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1142, doi. 10.1002/cpt.3585

By:

Bischof, Thorsten;
al Jalali, Valentin;
Zeitlinger, Markus;
Jorda, Anselm;
Hana, Michelle;
Singeorzan, Karla‐Nikita;
Riesenhuber, Nikolaus;
Stemer, Gunar;
Schoergenhofer, Christian

Publication type:

Article

On the Concepts, Methods, and Use of "Probability of Success" for Drug Development Decision‐Making: A Scoping Review.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 967, doi. 10.1002/cpt.3571

By:

Cetinyurek Yavuz, Aysun;
Fayyad, Muhammad Bergas Nur;
Jiang, Ce;
Brion Bouvier, Florie;
Beji, Celine;
Zebachi, Sonia;
Hayek, Ghinwa Y.;
Amzal, Billy;
Porcher, Raphael;
Tanniou, Julien;
Roes, Kit;
Rodwell, Laura

Publication type:

Article

Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1039, doi. 10.1002/cpt.3583

By:

Desai, Rishi J.;
Varma, Vijay R.;
Mahesri, Mufaddal;
Lee, Su Been;
Freedman, Ariel;
Gerhard, Tobias;
Segal, Jodi;
Vine, Seanna;
Ritchey, Mary Beth E.;
Horton, Daniel B.;
Thambisetty, Madhav

Publication type:

Article

Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1106, doi. 10.1002/cpt.3569

By:

Essink, Sharon C. M.;
Zomerdijk, Inge M.;
Goedecke, Thomas;
Straus, Sabine M. J. M.;
Gardarsdottir, Helga;
De Bruin, Marie L.

Publication type:

Article

Decision‐Making Criteria and Methods for Initiating Late‐Stage Clinical Trials in Drug Development From a Multi‐Stakeholder Perspective: A Scoping Review.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 978, doi. 10.1002/cpt.3566

By:

Jiang, Ce;
Beji, Céline;
Zebachi, Sonia;
Hayek, Ghinwa Y.;
Cetinyurek‐Yavuz, Aysun;
Fayyad, Muhammad Bergas N.;
Rodwell, Laura;
Roes, Kit C. B.;
Amzal, Billy;
Gerlinger, Christoph;
Porcher, Raphaël;
Tanniou, Julien

Publication type:

Article

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real‐World Evidence.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 927, doi. 10.1002/cpt.3563

By:

Hernandez, Rohini K.;
Critchlow, Cathy W.;
Dreyer, Nancy;
Lash, Timothy L.;
Reynolds, Robert F.;
Sørensen, Henrik T.;
Lange, Jeff L.;
Gatto, Nicolle M.;
Sobel, Rachel E.;
Lai, Edward Chia‐Cheng;
Schoonen, Marieke;
Brown, Jeffrey S.;
Christian, Jennifer B.;
Brookhart, M. Alan;
Bradbury, Brian D.

Publication type:

Article

Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 920, doi. 10.1002/cpt.3556

By:

Grueger, Jens;
Srikant, Vaidyanathan

Publication type:

Article

Demonstration of Major Therapeutic Advantage From a Review of EU Conditional Marketing Authorizations in Oncology and Hematology.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1098, doi. 10.1002/cpt.3554

By:

Lasch, Florian;
Carvalho, Joana R. B.;
Pothet, Caroline

Publication type:

Article

Progress, Pitfalls, and Impact of AI‐Driven Clinical Trials.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 887, doi. 10.1002/cpt.3542

By:

Wilczok, Dominika;
Zhavoronkov, Alex

Publication type:

Article

Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1017, doi. 10.1002/cpt.3545

By:

Koo, Hyunwoo;
Smith, Tayler B.;
Callaghan, John T.;
Osei, Wilberforce;
Bray, Steven M.;
Tillman, Emma M.;
Tran, Mya T.;
Fausel, Christopher A.;
Schneider, Bryan P.;
Shugg, Tyler;
Skaar, Todd C.

Publication type:

Article

Factors Influencing Medication Adherence in Heart Failure Patients—A Survey Among Cardiac Healthcare Providers.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1088, doi. 10.1002/cpt.3526

By:

Gunnthorsdottir, Ingibjorg;
Almarsdottir, Anna Birna;
Andersen, Karl;
Gunnarsdottir, Anna I.;
Svansdottir, Erla;
Einarsson, Hafsteinn;
Ingimarsdottir, Inga Jona

Publication type:

Article

POP‐REFINE: A Comprehensive Framework for Evaluating and Optimizing Representativeness in Clinical Trials.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1051, doi. 10.1002/cpt.3543

By:

Benedum, Corey M.;
Sarkar, Somnath;
Bozkurt, Selen;
Bhagat, Ruma;
Richie, Nicole;
Lavery, Bea;
Griffith, Sandra D.

Publication type:

Article

Investigational Use of Real‐World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1021, doi. 10.1002/cpt.3528

By:

Ko, Andrew H.;
Oh, Do‐Youn;
Lau, Janet;
Mhatre, Shivani K.;
Ci, Bo;
Machado, Robson;
Li, Shi;
Bretscher, Michael T.;
Reyes‐Rivera, Irmarie;
Zhu, Jiawen;
Zhang, Xiaosong;
Patel, Jilpa;
Psioda, Matthew A.;
Ponz‐Sarvise, Mariano

Publication type:

Article

PMDA Perspective on Use of Real‐World Data and Real‐World Evidence as an External Control: Recent Examples and Considerations.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 910, doi. 10.1002/cpt.3540

By:

Asano, Junichi;
Sugano, Hiromi;
Murakami, Hiroyuki;
Noguchi, Atsushi;
Ando, Yuki;
Uyama, Yoshiaki

Publication type:

Article

The Open Hand Initiative: Facilitating the Use of Real‐World Evidence in Regulatory Submissions Through Collaboration and Transparency.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1072, doi. 10.1002/cpt.3539

By:

Baumfeld Andre, Elodie;
Gee, Matthew;
Magnus, Carsten;
Greeman, Stephanie;
White, Pipper;
de Mars, Maryellen;
Spring, Brad

Publication type:

Article

Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1005, doi. 10.1002/cpt.3530

By:

Chu, Patricia Y.;
Edmondson, Emma K.;
Flory, James H.;
Huang, Jing;
Hennessy, Sean

Publication type:

Article

Contemporary Use of β‐Blockers in Heart Failure Patients With and Without Atrial Fibrillation: A Nationwide Database Analysis.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1061, doi. 10.1002/cpt.3496

By:

Nakai, Michikazu;
Iwanaga, Yoshitaka;
Kanaoka, Koshiro;
Sumita, Yoko;
Nishioka, Yuichi;
Myojin, Tomoya;
Okada, Katsuki;
Noda, Tatsuya;
Imamura, Tomoaki;
Miyamoto, Yoshihiro

Publication type:

Article

Discovering Severe Adverse Reactions From Pharmacokinetic Drug–Drug Interactions Through Literature Analysis and Electronic Health Record Verification.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1078, doi. 10.1002/cpt.3500

By:

Jeong, Eugene;
Su, Yu;
Li, Lang;
Chen, You

Publication type:

Article

Real‐World Effectiveness of All‐Oral Direct‐Acting Antivirals in Patients With Hepatitis C Virus‐Related HCC.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1030, doi. 10.1002/cpt.3481

By:

Chang, Shao‐Hsuan;
Cabrera, Roniel;
Heo, Jihaeng;
Park, Chanhyun;
Guo, Jingchuan;
Park, Haesuk

Publication type:

Article

A Systematic Review of the Costs of Drug‐Associated Acute Kidney Injury and Potential Cost Savings With Nephrotoxin Stewardship Prevention Strategies.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 989, doi. 10.1002/cpt.3493

By:

Stottlemyer, Britney A.;
Tran, Tiffany;
Suh, Kangho;
Kane‐Gill, Sandra L.

Publication type:

Article

Concomitant Use of Oral Anticoagulants With Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1012, doi. 10.1002/cpt.3442

By:

Pham Nguyen, Thanh Phuong;
Leonard, Charles E.;
Brensinger, Colleen M.;
Bilker, Warren B.;
Chung, Sophie P.;
Horn, John R.;
Bogar, Kacie;
Miano, Todd A.;
Hennessy, Sean

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 859, doi. 10.1002/cpt.3320
Publication type:: Article